| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Chest Pain | |||||
| Sickle Cell Anemia | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Anemia | |||||
| Anemia, Sickle Cell | |||||
| 3 | More general conditions related to this trial | ||||
| Anemia, Hemolytic | |||||
| Anemia, Hemolytic, Congenital | |||||
| Genetic Diseases, Inborn | |||||
| Hematologic Diseases | |||||
| Hemoglobinopathies | |||||
| Pain | |||||
| Signs and Symptoms | |||||
| 4 | Interventions listed in this trial | ||||
| Nitric Oxide | |||||
| Nitroglycerin | |||||
| 5 | More general drug interventions related to this trial | ||||
| Anti-Asthmatic Agents | |||||
| Antioxidants | |||||
| Autonomic Agents | |||||
| Bronchodilator Agents | |||||
| Cardiovascular Agents | |||||
| Endothelium-Dependent Relaxing Factors | |||||
| Free Radical Scavengers | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Neurotransmitter Agents | |||||
| Peripheral Nervous System Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Protective Agents | |||||
| Respiratory System Agents | |||||
| Therapeutic Uses | |||||
| Vasodilator Agents | |||||
| 6 | Sponsors listed in this trial | ||||
| National Institutes of Health Clinical Center (CC) | |||||
|
